Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Adverum Biotechnologies (ADVM) has a market cap of $64.005 million USD. According to our data, Adverum Biotechnologies is ranked No.7897 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $64.01 M |
-34.12%
|
| Dec 31, 2024 | $97.15 M |
-37.98%
|
| Dec 29, 2023 | $0.16 B |
29.83%
|
| Dec 30, 2022 | $0.12 B |
-67.05%
|
| Dec 31, 2021 | $0.37 B |
-83.76%
|
| Dec 31, 2020 | $2.25 B |
-5.90%
|
| Dec 31, 2019 | $2.40 B |
265.71%
|
| Dec 31, 2018 | $0.66 B |
-10.00%
|
| Dec 29, 2017 | $0.73 B |
20.69%
|
| Dec 30, 2016 | $0.60 B |
-69.54%
|
| Dec 31, 2015 | $1.98 B |
-82.37%
|
| Dec 31, 2014 | $11.23 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 REGENXBIO
RGNX
|
$0.31 B |
-0.019 B
|
USA
|
 Editas Medicine
EDIT
|
$0.11 B |
-4.979 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.16 B |
-8.966 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.22 B |
-0.124 B
|
Switzerland
|
 bluebird bio
BLUE
|
$41.02 M |
-2.741 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.33 B |
50.456 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.73 B |
-0.036 B
|
USA
|
 Allogene Therapeutics
ALLO
|
$0.31 B |
-9.777 M
|
USA
|
 Agios Pharmaceuticals
AGIO
|
$1.57 B |
-0.028 B
|
USA
|
 PTC Therapeutics
PTCT
|
$3.61 B |
-0.088 B
|
USA
|
 Boundless Bio
BOLD
|
$29.32 M |
-0.780 M
|
USA
|
 Voyager Therapeutics
VYGR
|
$0.17 B |
-4.969 M
|
USA
|
| Market Cap | = | ADVM Stock Price | * | ADVM Shares Outstanding |
| = | $3.08 | * | 20.80 M | |
| = | $64.01 M |